First-Line Afatinib plus Cetuximab for EGFR-Mutant Non–Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study
暂无分享，去创建一个
O. Molinier | M. Denis | D. Moro-Sibilot | E. Quoix | E. Giroux-Leprieur | L. Moreau | F. Morin | D. Debieuvre | J. Cadranel | A. Cortot | E. Amour | H. Bérard | H. Morel | E. Pichon | J. Otto | A. Madroszyk | J. Raimbourg | J. Hureaux | A. Renault | S. Charpentier | Benjamin Huret | Isabelle Rault | E. Giroux-Leprieur